Get the Stockscreener App
13.72
12.00%
1.47
After Hours:
13.76
0.04
+0.29%
Shoulder Innovations Inc stock is traded at $13.72, with a volume of 153.77K.
It is up +12.00% in the last 24 hours and down -3.18% over the past month.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
See More
Previous Close:
$12.25
Open:
$12.74
24h Volume:
153.77K
Relative Volume:
2.46
Market Cap:
$282.66M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.4579
EPS:
-29.96
Net Cash Flow:
-
1W Performance:
+9.15%
1M Performance:
-3.18%
6M Performance:
+4.33%
1Y Performance:
+988.98%
1-Day Range:
$12.11
$14.05
1-Week Range:
$12.00
$14.05
52-Week Range:
$10.92
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Name
Shoulder Innovations Inc
Sector
Industry
Phone
616-566-0286
Address
13827 PORT SHELDON STREET, HOLLAND
Compare SI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
13.72 | 252.37M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | BTIG Research | Buy |
| Aug-25-25 | Initiated | Goldman | Buy |
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-25-25 | Initiated | Piper Sandler | Overweight |
| Mar-06-23 | Downgrade | Compass Point | Neutral → Sell |
| Mar-06-23 | Downgrade | Wedbush | Neutral → Underperform |
| Mar-02-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-23 | Downgrade | Compass Point | Buy → Neutral |
| Mar-02-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-01-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-06-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-12-22 | Reiterated | Wedbush | Outperform |
| Dec-05-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-21-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-10-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-22 | Downgrade | Goldman | Buy → Neutral |
| Oct-06-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Aug-04-22 | Initiated | BTIG Research | Buy |
| Jun-13-22 | Initiated | Wells Fargo | Overweight |
| Jun-09-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-21-22 | Initiated | BofA Securities | Buy |
| Jan-20-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-16-21 | Initiated | B. Riley Securities | Buy |
| Nov-11-21 | Initiated | JP Morgan | Overweight |
| Nov-08-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-27-21 | Initiated | Morgan Stanley | Overweight |
| Jun-14-21 | Initiated | Goldman | Neutral |
| Jan-14-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-22-20 | Initiated | Wedbush | Outperform |
| Dec-17-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Dec-02-20 | Initiated | Craig Hallum | Buy |
| Oct-16-20 | Initiated | Compass Point | Buy |
| Mar-16-20 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | Keefe Bruyette | Mkt Perform |
| Dec-02-19 | Initiated | Barclays | Overweight |
| Nov-18-19 | Initiated | Compass Point | Buy |
View All
Shoulder Innovations Inc Stock (SI) Latest News
Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - BioSpace
Critical Survey: Biosig Technologies (NASDAQ:STEX) and Shoulder Innovations (NYSE:SI) - Defense World
Analysts Conflicted on These Healthcare Names: Align Tech (ALGN) and Boston Scientific (BSX) - The Globe and Mail
Is Shoulder Innovations (NYSE:SI) Weighed On By Its Debt Load? - simplywall.st
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), GE Healthcare Technologies Inc (GEHC) and Merck & Company (MRK) - The Globe and Mail
Federated Hermes Inc. Acquires Shares of 200,000 Shoulder Innovations, Inc. $SI - MarketBeat
Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - BioSpace
With 38% stake, Shoulder Innovations, Inc. (NYSE:SI) seems to have captured institutional investors' interest - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Soleno Therapeutics (SLNO) - The Globe and Mail
FY2027 Earnings Estimate for Stantec Issued By Scotiabank - Defense World
Shoulder Innovations, Inc. (NYSE:SI) Receives $20.60 Average Price Target from Analysts - Defense World
Shoulder Innovations, Inc. (NYSE:SI) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Rob Ball | Crain’s Newsmakers 2025 - Crain's Grand Rapids Business
Shoulder Innovations, Inc.'s (NYSE:SI) Lock-Up Period To End on January 27th - MarketBeat
LPCVU’s Quiet Period To End on January 27th (NASDAQ:LPCVU) - Defense World
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Penumbra (PEN) - The Globe and Mail
Critical Contrast: Perspective Therapeutics (NASDAQ:CATX) and Shoulder Innovations (NYSE:SI) - Defense World
Impulse Dynamics® Announces New Chief Financial Officer - The Manila Times
Impulse Dynamics - Via Ritzau
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Insider Trends: How cyclical is Shoulder Innovations Inc stock compared to rivalsPrice Action & Fast Momentum Stock Entry Tips - moha.gov.vn
SI SEC FilingsShoulder Innovations, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Shoulder Innovations price target raised to $20 from $19 at Goldman Sachs - TipRanks
Shoulder Innovations (SI) CFO buys 1,076 ESPP shares, now holds 55,521 directly - Stock Titan
Shoulder Innovations (SI) officer adds 1,041 ESPP shares - Stock Titan
Shoulder Innovations (SI) CEO Robert Ball acquires ESPP shares, now holds 120,118 - Stock Titan
[Form 4] SHOULDER INNOVATIONS, INC. Insider Trading Activity - Stock Titan
What analyst consensus implies for Shoulder Innovations Inc. stock2025 EndofYear Setup & Growth Focused Investment Plans - Улправда
Texas Community Bancshares (NASDAQ:TCBS) Stock Price Down 3.8% – Should You Sell? - Defense World
Daily Breeze: Local News, Sports, Things to DoShoulder Innovations, Inc. Common Stock (NYSE:SI) Stock Quote - FinancialContent
What downside risks could hit Shoulder Innovations Inc. stockTrading Volume Surges & High Return Trading Portfolio - bollywoodhelpline.com
US Market Recap: What analyst consensus implies for Shoulder Innovations Inc stockFed Meeting & Low Risk Entry Point Tips - Bộ Nội Vụ
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Avalo Therapeutics (AVTX) and Lifestance Health Group (LFST) - The Globe and Mail
Shoulder Innovations Inc (NYSE: SI)Share Price and Research - intelligentinvestor.com.au
Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Glaukos (GKOS) - The Globe and Mail
FOMO Trade: Is Shoulder Innovations Inc stock a safe buy pre earningsDay Trade & Verified Swing Trading Watchlist - moha.gov.vn
Analysts Conflicted on These Healthcare Names: InflaRx (IFRX) and Globus Medical (GMED) - The Globe and Mail
Shoulder Innovations, Inc. Common Stock (NY: SI - FinancialContent
Insiders Made Their Bets in 2025-These Were the Top 5 Stocks They Bought - Finviz
Shoulder Innovations, Inc. (NYSE:SI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations, Inc. (NYSE:SI) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
Shoulder Innovations: Interesting, But Not Having My Backing Yet - Seeking Alpha
Is Shoulder Innovations Inc. stock undervalued at current priceMarket Rally & Free Low Drawdown Momentum Trade Ideas - DonanımHaber
How Shoulder Innovations Inc. stock reacts to weak economyTrade Ideas & Real-Time Buy Zone Alerts - DonanımHaber
Shoulder Innovations (SI) – Investment Analysts’ Weekly Ratings Updates - Defense World
ENvue Medical, Inc. (FEED) Competitors - Meyka
Book value per share of Shoulder Innovations, Inc. – DUS:VB3 - TradingView — Track All Markets
Shoulder innovations CFO points buys shares worth $29,631 By Investing.com - Investing.com South Africa
Top Executives Make Significant Stock Purchases at Shoulder Innovations! - TipRanks
Shoulder Innovations Inc Stock (SI) Financials Data
There is no financial data for Shoulder Innovations Inc (SI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):